Total Payments
$4,469
2023 Payments
$41.53
Companies
29
Transactions
329
Medicare Patients
2,126
Medicare Billing
$254,380

Payment Breakdown by Category

Food & Beverage$4,459 (99.8%)
Education$10.66 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,459 327 99.8%
Education $10.66 2 0.2%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,301 71 $0 (2020)
Novo Nordisk Inc $608.95 57 $0 (2020)
Janssen Pharmaceuticals, Inc $423.65 53 $0 (2020)
GlaxoSmithKline, LLC. $379.64 27 $0 (2021)
SANOFI-AVENTIS U.S. LLC $247.57 18 $0 (2020)
Astellas Pharma US Inc $192.38 12 $0 (2020)
Abbott Laboratories $177.01 10 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $131.94 9 $0 (2019)
PFIZER INC. $123.63 10 $0 (2020)
Merck Sharp & Dohme Corporation $109.18 9 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2023 $41.53 2 Abbott Laboratories ($41.53)
2021 $27.52 2 GlaxoSmithKline, LLC. ($14.13)
2020 $811.62 55 AstraZeneca Pharmaceuticals LP ($391.25)
2019 $1,270 91 AstraZeneca Pharmaceuticals LP ($400.18)
2018 $1,283 99 AstraZeneca Pharmaceuticals LP ($303.55)
2017 $1,036 80 AstraZeneca Pharmaceuticals LP ($206.28)

All Payment Transactions

329 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
10/13/2023 Abbott Laboratories ETERNA (Device) Food and Beverage In-kind items and services $24.57 General
Category: Neuromodulation
07/10/2023 Abbott Laboratories PRODIGY (Device) Food and Beverage In-kind items and services $16.96 General
Category: Neuromodulation
08/24/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.39 General
Category: NEUROSCIENCE
04/14/2021 GlaxoSmithKline, LLC. SHINGRIX (Biological) Food and Beverage In-kind items and services $14.13 General
Category: VACCINES
11/19/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $18.02 General
Category: Diabetes
11/17/2020 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $14.47 General
Category: Respiratory
11/05/2020 Astellas Pharma US Inc MYRBETRIQ (Drug) Food and Beverage In-kind items and services $19.33 General
Category: UROLOGY
11/04/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.74 General
Category: Cardiovascular and Metabolism
10/28/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $19.68 General
Category: Diabetes
10/13/2020 AstraZeneca Pharmaceuticals LP BREZTRI AEROSPHERE (Drug) Food and Beverage In-kind items and services $12.29 General
Category: Respiratory
10/07/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.64 General
Category: Cardiovascular and Metabolism
09/30/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.13 General
Category: Cardiovascular and Metabolism
09/23/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.82 General
Category: Cardiovascular and Metabolism
09/16/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.22 General
Category: Cardiovascular and Metabolism
09/15/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $14.24 General
Category: Diabetes
09/09/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.62 General
Category: Cardiovascular and Metabolism
09/02/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.35 General
Category: Cardiovascular and Metabolism
08/25/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $13.73 General
Category: Diabetes
08/12/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $12.62 General
Category: Cardiovascular and Metabolism
08/11/2020 SANOFI-AVENTIS U.S. LLC SOLIQUA 100/33 (Biological) Food and Beverage In-kind items and services $11.23 General
Category: Endocrinology
07/30/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $15.91 General
Category: Diabetes
07/29/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.43 General
Category: Cardiovascular and Metabolism
07/15/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $11.04 General
Category: Cardiovascular and Metabolism
07/14/2020 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $11.40 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
07/08/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $11.17 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 318 511 $144,685 $46,916
2022 8 441 901 $209,010 $66,461
2021 10 494 859 $210,185 $69,650
2020 20 873 1,282 $157,101 $71,352
Total Patients
2,126
Total Services
3,553
Medicare Billing
$254,380
Procedure Codes
44

All Medicare Procedures & Services

44 procedure records from CMS Medicare Utilization — Page 2 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 112 173 $20,705 $8,998 43.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 58 140 $18,628 $8,414 45.2%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 21 22 $8,495 $3,724 43.8%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 29 36 $7,270 $3,124 43.0%
99495 Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge Office 2020 18 20 $6,508 $3,090 47.5%
G0180 Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem Office 2020 42 45 $4,120 $1,956 47.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 16 16 $2,864 $1,941 67.8%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 16 22 $4,038 $1,920 47.5%
99497 Advance care planning by the physician or other qualified health care professional Office 2020 25 25 $3,449 $1,889 54.8%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 20 20 $5,550 $1,878 33.8%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2020 24 49 $2,989 $1,621 54.2%
G0444 Annual depression screening, 15 minutes Office 2020 133 133 $2,185 $1,461 66.9%
90662 Vaccine for influenza for injection into muscle Office 2020 22 22 $1,848 $1,342 72.6%
99217 Hospital observation care on day of discharge Facility 2020 13 14 $1,839 $852.61 46.4%
G0179 Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp Office 2020 15 22 $1,601 $717.51 44.8%
83036 Hemoglobin a1c level Office 2020 35 54 $1,236 $505.59 40.9%
G0008 Administration of influenza virus vaccine Office 2020 28 29 $830.00 $496.62 59.8%
81002 Urinalysis, manual test Office 2020 49 74 $522.00 $255.21 48.9%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 12 12 $330.00 $141.95 43.0%

About Venessa Tan, MD, MPH

Venessa Tan, MD, MPH is a Student in an Organized Health Care Education/Training Program healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1780845669.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Venessa Tan, MD, MPH has received a total of $4,469 in payments from pharmaceutical and medical device companies, with $41.53 received in 2023. These payments were reported across 329 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,459).

As a Medicare-enrolled provider, Tan has provided services to 2,126 Medicare beneficiaries, totaling 3,553 services with total Medicare billing of $254,380. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.

Practice Information

Products in Payments

  • FARXIGA (Drug) $1,085
  • XARELTO (Drug) $390.07
  • Ozempic (Drug) $223.14
  • TOUJEO (Drug) $178.97
  • TRELEGY ELLIPTA (Drug) $169.30
  • XIFAXAN (Drug) $152.06
  • Saxenda (Drug) $130.70
  • Victoza (Drug) $121.95
  • AFREZZA (Drug) $106.97
  • JARDIANCE (Drug) $104.76
  • Myrbetriq (Drug) $94.98
  • Prolia (Biological) $80.58
  • FreeStyle Libre (Device) $75.26
  • PNEUMOVAX 23 (Biological) $73.19
  • Tresiba (Drug) $68.99
  • ADVAIR (Drug) $65.91
  • MYRBETRIQ (Drug) $64.29
  • BYDUREON (Drug) $63.01
  • CHANTIX (Drug) $61.71
  • ENTRESTO (Drug) $58.14

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Stony Brook